Anant Ramaswamy

17PUBLICATIONS
62CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Solid tumoursEvolution of developmental systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 10, 2026
The Role of Serial Serum Carbohydrate Antigen 19-9 Surveillance to Detect Recurrences after Curative Resection for Gallbladder Carcinoma.

|Mar 11, 2026
Carica Papaya Leaf Extract to Improve Chemotherapy-Induced Thrombocytopenia: A Phase III Triple-Blinded, Randomized, Placebo-Controlled, Multicentric Trial.

Vikas Ostwal, Manali Parulekar, Deepali Naughane

|Jan 28, 2026
Efficacy and Safety of Ultra-Low-Dose Immunotherapy in Relapsed Refractory Solid Tumors: Phase III Superiority Randomized Trial (DELII).

Vanita Noronha, Vijay Patil, Nandini Menon

|Nov 19, 2025
Practice Patterns and Outcomes in Advanced Colorectal Cancers From a Multi-Institutional Analysis: Real-World Evidence From India.

Anant Ramaswamy, Ramjas Prajapati, Vivek Agarwala

|Aug 12, 2025
Predicting clinical benefit response after neoadjuvant chemotherapy in locally advanced gallbladder cancer: retrospective analysis.

Shraddha Patkar, Kaival Gundavda, Kaushik Polusany

|Jun 21, 2025
Efficacy of losartan plus modified FOLFIRINOX versus modified FOLFIRINOX in advanced pancreatic cancers: A randomized clinical trial (AFPAC Study).

Anant Ramaswamy, Prabhat Bhargava, Vikram Gota

Pageof 3

Frequent Collaborators

13 joint publications

Vikas S Ostwal

9 joint publications

Prabhat Bhargava

4 joint publications

Sujay Srinivas

4 joint publications

Rajiv Kumar Kaushal